CVSGF (CVS Group) EPS without NRI: $1.11 (TTM As of Dec. 2025)


CVSGF CVS Group PLC CVSGF
90 GF Score
Price $16.55
GF Value $17.89
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is CVS Group EPS without NRI?

CVS Group CVSGF 90 EPS without NRI is $1.11 as of Dec. 2025. GuruFocus rates CVSGF with a GF Score™ of 90/100 and a GF Value™ of $17.89 (Fairly Valued). The stock has 3 warning signs investors should review. Among 511 Healthcare Providers & Services companies, CVS Group ranks worse than 68.88% on this metric.

CVS Group's earnings per share without non-recurring items for the six months ended in Dec. 2025 was $0.54. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was $1.11.

During the past 12 months, CVS Group's average earnings per share (NRI) Growth Rate was 12.70% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was -2.00% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 11.20% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 13.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for CVS Group's EPS without NRI or its related term are showing as below:

CVSGF' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -2   Med: 17.9   Max: 43.4
Current: -2

During the past 13 years, CVS Group's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 43.40% per year. The lowest was -2.00% per year. And the median was 17.90% per year.

CVSGF's 3-Year EPS without NRI Growth Rate is ranked worse than
68.88% of 511 companies
in the Healthcare Providers & Services industry
Industry Median: 11.3 vs CVSGF: -2.00

CVS Group's EPS (Diluted) for the six months ended in Dec. 2025 was $0.15. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.93.

CVS Group's EPS (Basic) for the six months ended in Dec. 2025 was $0.15. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.93.


CVS Group  (OTCPK:CVSGF) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


CVS Group EPS without NRI Related Terms


CVS Group EPS without NRI Historical Data

* Premium members only.

The historical data trend for CVS Group's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CVS Group EPS without NRI Chart

CVS Group Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.05 1.05 1.24 1.06 1.09

CVS Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.61 0.45 0.48 0.57 0.54

CVSGF vs HCA, THC, DVA: EPS without NRI Comparison

For the Medical Care Facilities subindustry, CVS Group's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CVS Group PE Ratio without NRI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, CVS Group's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where CVS Group's PE Ratio without NRI falls into.


CVSGF
90GF Score
CVS Group PLC CVSGF
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CVS Group EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $1.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $1.11 mean?
CVS Group (CVSGF) has a EPS without NRI of $1.11 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on CVS Group and its competitors. According to the industry distribution chart, CVS Group ranks #352 out of 511 companies in the Healthcare Providers & Services industry, placing it in the top 68.9%.
Is CVS Group's EPS without NRI too high?
CVS Group's current EPS without NRI is $1.11. The Healthcare Providers & Services industry median EPS without NRI is 11.30. CVS Group's value of $1.11 is 90.2% below this industry median. Based on the distribution chart, CVS Group ranks #352 out of 511 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, CVS Group has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CVS Group's EPS without NRI compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, CVS Group ranks #352 out of 511 companies for EPS without NRI. This places CVS Group in the lower half of its industry. The industry median EPS without NRI is 11.30. CVS Group's value of $1.11 is 90.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.30, based on 511 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CVS Group's current EPS without NRI of $1.11 is 90.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on CVS Group and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CVS Group's current EPS without NRI is $1.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVS Group stock overvalued right now?
Based on GuruFocus' analysis, CVS Group (CVSGF) is currently considered Fairly Valued. The stock's GF Value™ is $17.89, compared to a current price of $16.55 — trading 7.5% below its estimated fair value. The current EPS without NRI is $1.11 and 90.2% below the Healthcare Providers & Services industry median of 11.30. CVS Group's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For CVS Group (CVSGF), the current EPS without NRI is $1.11 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CVS Group (CVSGF) Overvalued in 2026?

Based on GuruFocus' analysis, CVS Group stock appears to be undervalued. The current stock price of $16.55 is trading 7.5% below its estimated GF Value™ of $17.89. GuruFocus considers CVS Group to be Fairly Valued.

Key valuation signals for CVSGF:

  • EPS without NRI: $1.11
  • GF Value™: $17.89 vs. price of $16.55 (7.5% below fair value)
  • GF Score™: 90/100 with 3 warning signs
  • Industry Position: 90.2% below the Healthcare Providers & Services median (#352 of 511)

No single metric tells the full story. See the CVSGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CVS Group Business Description

Other Exchanges CVSGl:UKCVSG:UK4C9:Germany
Address Owen Road, CVS House, Diss, Norfolk, GBR, IP22 4ER
CVS Group PLC is a veterinary service provider in the United Kingdom. The group operates through three business divisions: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. The veterinary practice segment generates the majority of the revenues. The company facilitates its veterinary services through its diagnostics, laboratory reports, and pet cremation services. It also offers retail pharmacy through Animed Direct. Geographically, it generates the majority of its revenue from the United Kingdom and also operates in Australia.
90GF Score

Get the complete analysis for CVSGF

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.55
Price
$17.89
GF Value